The Canagliflozin market was valued at USD 2.75 Billion in 2024 and is expected to reach USD 4.35 Billion by 2032, growing at a CAGR of 6.1% (2024-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.